AI-generated summary
The authors studied 36 cancer patients with oral mucositis, assigning them by convenience to photodynamic therapy with photobiomodulation, the same plus intravascular laser irradiation of blood, or intravascular laser irradiation alone. They report a significant reduction in mucositis severity in all three groups over five weekly sessions. The study used a small, non-randomized convenience allocation, so the findings are preliminary.
- Participants
- 36
- Who or what was studied
- Cancer patients with oral mucositis
- Wavelengths
- 468, 660 nm
- Limits stated in the abstract
- Patients were allocated by convenience into small, unequal groups, and the abstract reports no control group or randomization.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 468 nm, 660 nm
- Power
- 1200 mW, 100 mW
- Total energy
- 1 J, 30 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy, Photobiomodulation, Laser, Wavelength, Light-emitting diode, Photobiomodulation therapy, Trial registration, Oral mucositis. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.